 Erin McNulty
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wasting Disease, Chronic | 15 | 2025 | 26 | 3.480 |
Why?
| | Deer | 13 | 2025 | 34 | 3.020 |
Why?
| | Prions | 14 | 2025 | 49 | 2.350 |
Why?
| | Bluetongue virus | 4 | 2026 | 5 | 0.850 |
Why?
| | Bluetongue | 4 | 2026 | 6 | 0.840 |
Why?
| | Nucleic Acid Amplification Techniques | 2 | 2020 | 39 | 0.740 |
Why?
| | Amyloid | 2 | 2020 | 90 | 0.700 |
Why?
| | PrPC Proteins | 1 | 2020 | 4 | 0.630 |
Why?
| | Biological Assay | 2 | 2019 | 128 | 0.590 |
Why?
| | Animal Experimentation | 1 | 2016 | 8 | 0.480 |
Why?
| | Animal Husbandry | 1 | 2016 | 37 | 0.460 |
Why?
| | Saliva | 4 | 2024 | 247 | 0.440 |
Why?
| | Brain | 3 | 2020 | 2934 | 0.380 |
Why?
| | Muntjacs | 4 | 2017 | 6 | 0.370 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2025 | 193 | 0.360 |
Why?
| | Animals | 23 | 2026 | 37948 | 0.270 |
Why?
| | Fetus | 2 | 2021 | 800 | 0.250 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2021 | 431 | 0.250 |
Why?
| | Animals, Genetically Modified | 2 | 2024 | 245 | 0.240 |
Why?
| | Creutzfeldt-Jakob Syndrome | 2 | 2024 | 18 | 0.240 |
Why?
| | Prion Proteins | 3 | 2022 | 4 | 0.240 |
Why?
| | Models, Immunological | 1 | 2026 | 100 | 0.230 |
Why?
| | Mice, Transgenic | 3 | 2020 | 2184 | 0.230 |
Why?
| | Adaptive Immunity | 1 | 2026 | 169 | 0.220 |
Why?
| | Ceratopogonidae | 1 | 2024 | 2 | 0.220 |
Why?
| | Carotid Body | 1 | 2024 | 1 | 0.220 |
Why?
| | Serogroup | 1 | 2024 | 45 | 0.210 |
Why?
| | Sheep | 5 | 2026 | 880 | 0.210 |
Why?
| | Mast Cells | 1 | 2024 | 148 | 0.190 |
Why?
| | Prion Diseases | 1 | 2022 | 15 | 0.190 |
Why?
| | Sheep Diseases | 1 | 2022 | 9 | 0.180 |
Why?
| | Lymph Nodes | 1 | 2024 | 501 | 0.170 |
Why?
| | Mice | 6 | 2025 | 18261 | 0.160 |
Why?
| | Mesocricetus | 1 | 2020 | 46 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 150 | 0.160 |
Why?
| | Immunity, Innate | 1 | 2026 | 843 | 0.160 |
Why?
| | Zika Virus | 1 | 2021 | 135 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2026 | 915 | 0.150 |
Why?
| | Fetal Diseases | 1 | 2021 | 193 | 0.150 |
Why?
| | Zika Virus Infection | 1 | 2021 | 171 | 0.150 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2020 | 339 | 0.150 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2942 | 0.140 |
Why?
| | Drosophila | 3 | 2024 | 167 | 0.130 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2017 | 19 | 0.130 |
Why?
| | Animal Structures | 1 | 2017 | 11 | 0.130 |
Why?
| | Antibodies, Viral | 3 | 2026 | 672 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1705 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2020 | 574 | 0.120 |
Why?
| | Housing, Animal | 1 | 2016 | 46 | 0.110 |
Why?
| | Placenta | 1 | 2021 | 781 | 0.110 |
Why?
| | Milk | 1 | 2014 | 119 | 0.100 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 51 | 0.100 |
Why?
| | Models, Statistical | 1 | 2017 | 677 | 0.100 |
Why?
| | Specimen Handling | 1 | 2014 | 187 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7122 | 0.090 |
Why?
| | Ultrasonography, Prenatal | 1 | 2014 | 293 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4539 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5957 | 0.070 |
Why?
| | Ganglia | 1 | 2024 | 18 | 0.050 |
Why?
| | Encephalopathy, Bovine Spongiform | 1 | 2024 | 4 | 0.050 |
Why?
| | Host Specificity | 1 | 2024 | 34 | 0.050 |
Why?
| | Female | 8 | 2025 | 78304 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2026 | 426 | 0.050 |
Why?
| | Reindeer | 1 | 2023 | 4 | 0.050 |
Why?
| | Muscles | 1 | 2024 | 332 | 0.050 |
Why?
| | Species Specificity | 1 | 2024 | 573 | 0.050 |
Why?
| | Viremia | 1 | 2023 | 159 | 0.050 |
Why?
| | Ruminants | 1 | 2022 | 7 | 0.050 |
Why?
| | RNA, Viral | 1 | 2026 | 689 | 0.050 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2022 | 76 | 0.050 |
Why?
| | West Virginia | 1 | 2021 | 9 | 0.040 |
Why?
| | Insect Vectors | 1 | 2022 | 39 | 0.040 |
Why?
| | Protein Aggregates | 1 | 2022 | 84 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 975 | 0.040 |
Why?
| | Vero Cells | 1 | 2021 | 84 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2021 | 160 | 0.040 |
Why?
| | Feces | 1 | 2024 | 513 | 0.040 |
Why?
| | Male | 5 | 2021 | 72431 | 0.040 |
Why?
| | Palatine Tonsil | 1 | 2020 | 55 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2020 | 78 | 0.040 |
Why?
| | Chemistry Techniques, Analytical | 1 | 2017 | 20 | 0.030 |
Why?
| | Administration, Oral | 1 | 2020 | 851 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 831 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 2017 | 177 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2045 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1984 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2024 | 1788 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3109 | 0.030 |
Why?
| | Abdomen | 1 | 2014 | 141 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1995 | 0.020 |
Why?
| | Models, Animal | 1 | 2014 | 393 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 2013 | 169 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2847 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 1993 | 192 | 0.020 |
Why?
| | Lymphocytes | 1 | 1993 | 379 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 613 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5967 | 0.020 |
Why?
| | Humans | 5 | 2024 | 144671 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1847 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1993 | 1246 | 0.020 |
Why?
| | Mothers | 1 | 2013 | 765 | 0.020 |
Why?
| | United States | 1 | 2024 | 16018 | 0.020 |
Why?
| | HIV-1 | 1 | 1993 | 897 | 0.020 |
Why?
| | Genes, tat | 1 | 1993 | 3 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1993 | 35 | 0.010 |
Why?
| | DNA, Recombinant | 1 | 1993 | 48 | 0.010 |
Why?
| | HIV Long Terminal Repeat | 1 | 1993 | 12 | 0.010 |
Why?
| | Proviruses | 1 | 1993 | 16 | 0.010 |
Why?
| | TATA Box | 1 | 1993 | 21 | 0.010 |
Why?
| | Sp1 Transcription Factor | 1 | 1993 | 24 | 0.010 |
Why?
| | Gene Products, tat | 1 | 1993 | 22 | 0.010 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 1993 | 25 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1993 | 94 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 881 | 0.010 |
Why?
| | Genome, Viral | 1 | 1993 | 218 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 1993 | 372 | 0.010 |
Why?
| | Virus Replication | 1 | 1993 | 525 | 0.000 |
Why?
| | Base Sequence | 1 | 1993 | 2177 | 0.000 |
Why?
| | NF-kappa B | 1 | 1993 | 657 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2909 | 0.000 |
Why?
|
|
McNulty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|